• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙蛋白酶抑制蛋白通过维持自噬来防止血管紧张素 II 介导的足细胞损伤。

Calpastatin prevents Angiotensin II-mediated podocyte injury through maintenance of autophagy.

机构信息

Université de Paris, PARCC, Inserm, Paris, France.

Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

出版信息

Kidney Int. 2021 Jul;100(1):90-106. doi: 10.1016/j.kint.2021.02.024. Epub 2021 Mar 3.

DOI:10.1016/j.kint.2021.02.024
PMID:33675847
Abstract

The strong predictive value of proteinuria in chronic glomerulopathies is firmly established as well as the pathogenic role of angiotensin II promoting progression of glomerular disease with an altered glomerular filtration barrier, podocyte injury and scarring of glomeruli. Here we found that chronic angiotensin II-induced hypertension inhibited autophagy flux in mouse glomeruli. Deletion of Atg5 (a gene encoding a protein involved autophagy) specifically in the podocyte resulted in accelerated angiotensin II-induced podocytopathy, accentuated albuminuria and glomerulosclerosis. This indicates that autophagy is a key protective mechanism in the podocyte in this condition. Angiotensin-II induced calpain activity in podocytes inhibits autophagy flux. Podocytes from mice with transgenic expression of the endogenous calpain inhibitor calpastatin displayed higher podocyte autophagy at baseline that was resistant to angiotensin II-dependent inhibition. Also, sustained autophagy with calpastatin limited podocyte damage and albuminuria. These findings suggest that hypertension has pathogenic effects on the glomerular structure and function, in part through activation of calpains leading to blockade of podocyte autophagy. These findings uncover an original mechanism whereby angiotensin II-mediated hypertension inhibits autophagy via calcium-induced recruitment of calpain with pathogenic consequences in case of imbalance by calpastatin activity. Thus, preventing a calpain-mediated decrease in autophagy may be a promising new therapeutic strategy for nephropathies associated with high renin-angiotensin system activity.

摘要

蛋白尿在慢性肾小球疾病中有很强的预测价值,血管紧张素 II 促进肾小球疾病进展的致病作用也已得到确立,其作用机制为改变肾小球滤过屏障、足细胞损伤和肾小球瘢痕形成。在这里,我们发现慢性血管紧张素 II 诱导的高血压抑制了小鼠肾小球中的自噬流。特异性在足细胞中缺失 Atg5(编码参与自噬的蛋白质的基因)导致加速的血管紧张素 II 诱导的足细胞病变、加重白蛋白尿和肾小球硬化。这表明自噬是这种情况下足细胞中的一种关键保护机制。血管紧张素 II 诱导的足细胞钙蛋白酶活性抑制自噬流。来自转基因组内钙蛋白酶抑制剂钙蛋白酶抑制剂表达的小鼠的足细胞在基础水平显示出更高的自噬,对血管紧张素 II 依赖性抑制具有抗性。此外,持续的自噬与钙蛋白酶抑制剂一起限制了足细胞损伤和白蛋白尿。这些发现表明,高血压对肾小球的结构和功能具有致病作用,部分原因是通过钙依赖性募集钙蛋白酶激活,导致足细胞自噬受阻。这些发现揭示了一种原始机制,即血管紧张素 II 介导的高血压通过钙诱导的钙蛋白酶募集抑制自噬,而钙蛋白酶抑制剂的活性失衡则会产生致病后果。因此,预防钙蛋白酶介导的自噬减少可能是与高肾素-血管紧张素系统活性相关的肾病的一种有前途的新治疗策略。

相似文献

1
Calpastatin prevents Angiotensin II-mediated podocyte injury through maintenance of autophagy.钙蛋白酶抑制蛋白通过维持自噬来防止血管紧张素 II 介导的足细胞损伤。
Kidney Int. 2021 Jul;100(1):90-106. doi: 10.1016/j.kint.2021.02.024. Epub 2021 Mar 3.
2
Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.在糖尿病肾病的小鼠模型中,足细胞损伤涉及 TRPC6 介导的钙蛋白酶激活,从而损害自噬。
J Am Soc Nephrol. 2023 Nov 1;34(11):1823-1842. doi: 10.1681/ASN.0000000000000212. Epub 2023 Sep 6.
3
Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.内皮细胞和足细胞自噬协同保护免受糖尿病诱导的肾小球硬化。
Autophagy. 2015;11(7):1130-45. doi: 10.1080/15548627.2015.1049799.
4
Protective role of podocyte autophagy against glomerular endothelial dysfunction in diabetes.足细胞自噬在糖尿病肾小球内皮功能障碍中的保护作用。
Biochem Biophys Res Commun. 2020 Apr 30;525(2):319-325. doi: 10.1016/j.bbrc.2020.02.088. Epub 2020 Feb 20.
5
Inhibition of Endocytosis of Clathrin-Mediated Angiotensin II Receptor Type 1 in Podocytes Augments Glomerular Injury.足细胞网格蛋白介导的血管紧张素 II 受体 1 内吞作用抑制增强肾小球损伤。
J Am Soc Nephrol. 2019 Dec;30(12):2307-2320. doi: 10.1681/ASN.2019010053. Epub 2019 Sep 11.
6
Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members.血管紧张素II通过下调微小RNA-30家族成员来诱导钙/钙调神经磷酸酶信号传导和足细胞损伤。
J Mol Med (Berl). 2017 Aug;95(8):887-898. doi: 10.1007/s00109-017-1547-z. Epub 2017 May 24.
7
Renin-angiotensin system within the diabetic podocyte.糖尿病足细胞中的肾素-血管紧张素系统。
Am J Physiol Renal Physiol. 2015 Jan 1;308(1):F1-10. doi: 10.1152/ajprenal.00531.2013. Epub 2014 Oct 22.
8
Injured Podocytes Are Sensitized to Angiotensin II-Induced Calcium Signaling.受损足细胞对血管紧张素Ⅱ诱导的钙信号敏感。
J Am Soc Nephrol. 2020 Mar;31(3):532-542. doi: 10.1681/ASN.2019020109. Epub 2020 Jan 10.
9
Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.糖尿病肾小球病中足细胞病和蛋白尿的发病机制。
Curr Diabetes Rev. 2008 Feb;4(1):39-45. doi: 10.2174/157339908783502370.
10
Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.血管紧张素 II 依赖性肾小球不稳定导致的持续足细胞丢失引起终末期肾病进展。
Kidney Int. 2012 Jan;81(1):40-55. doi: 10.1038/ki.2011.306. Epub 2011 Sep 21.

引用本文的文献

1
Autophagy fine-tuning by angiotensin-(1-9) in cultured rat cardiomyocytes.血管紧张素-(1-9)对培养的大鼠心肌细胞自噬的精细调节
Front Cardiovasc Med. 2025 Mar 12;12:1408325. doi: 10.3389/fcvm.2025.1408325. eCollection 2025.
2
Epigenetics of Hypertensive Nephropathy.高血压肾病的表观遗传学
Biomedicines. 2024 Nov 16;12(11):2622. doi: 10.3390/biomedicines12112622.
3
Identification and Validation of the miR/RAS/RUNX2 Autophagy Regulatory Network in AngII-Induced Hypertensive Nephropathy in MPC5 Cells Treated with Hydrogen Sulfide Donors.
硫化氢供体处理的MPC5细胞中血管紧张素II诱导的高血压肾病中miR/RAS/RUNX2自噬调节网络的鉴定与验证
Antioxidants (Basel). 2024 Aug 7;13(8):958. doi: 10.3390/antiox13080958.
4
STAT3-induced upregulation of lncRNA TTN-AS1 aggravates podocyte injury in diabetic nephropathy by promoting oxidative stress.信号转导和转录激活因子3(STAT3)诱导的长链非编码RNA TTN-AS1上调通过促进氧化应激加重糖尿病肾病中的足细胞损伤。
Toxicol Res (Camb). 2024 May 31;13(3):tfae079. doi: 10.1093/toxres/tfae079. eCollection 2024 Jun.
5
Recent Advances in Proteinuric Kidney Disease/Nephrotic Syndrome: Lessons from Knockout/Transgenic Mouse Models.蛋白尿性肾病/肾病综合征的最新进展:基因敲除/转基因小鼠模型的经验教训
Biomedicines. 2023 Jun 23;11(7):1803. doi: 10.3390/biomedicines11071803.
6
Endothelial Autophagy Dysregulation in Diabetes.糖尿病中的内皮细胞自噬失调。
Cells. 2023 Mar 21;12(6):947. doi: 10.3390/cells12060947.
7
BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney disease.保肾通络方通过调节糖尿病肾病中AMPK介导的线粒体生物合成来预防足细胞损伤。
Chin Med. 2023 Mar 26;18(1):32. doi: 10.1186/s13020-023-00738-4.
8
Recent advances in molecular mechanisms of acute kidney injury in patients with diabetes mellitus.糖尿病患者急性肾损伤分子机制的最新进展。
Front Endocrinol (Lausanne). 2023 Jan 5;13:903970. doi: 10.3389/fendo.2022.903970. eCollection 2022.
9
The Perspective of Vitamin D on suPAR-Related AKI in COVID-19.维生素 D 对 COVID-19 中 suPAR 相关 AKI 的作用视角。
Int J Mol Sci. 2022 Sep 14;23(18):10725. doi: 10.3390/ijms231810725.
10
Enhanced Orai1-mediated store-operated Ca channel/calpain signaling contributes to high glucose-induced podocyte injury.增强的 Orai1 介导的钙库操纵钙通道/钙蛋白酶信号通路促进高糖诱导的足细胞损伤。
J Biol Chem. 2022 Jun;298(6):101990. doi: 10.1016/j.jbc.2022.101990. Epub 2022 Apr 29.